Chemical Compound

Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)

CAS Registry Number 145040-37-5
Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester) 结构式
Primary record

Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)

库存
900 克
纯度
99.8 %
CAS
145040-37-5

化合物标识与属性

CAS
145040-37-5
PubChem CID
2540
SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6
Canonical SMILES
CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1

名称与同义词

  • Candesartan cilexetil
  • Atacand
  • 145040-37-5
  • Blopress
  • Amias
  • candesartancilexetil
  • Parapres
  • Kenzen
  • Ratacand
  • TCV-116
  • candesartan
  • Racanda
  • candesartan cilexitil
  • CANDESARTAN CILEXTIL
  • Candesartan hexetil
  • Atacand (TN)
  • Candesartan cilexetil [USAN]
  • Candesartan cilexetil?
  • ATACAND HCT
  • Spectrum_001707
  • Candesartan Cilexetil-d11
  • TCV 116
  • RefChem:56666
  • DTXSID5020239
  • AC1L1DWQ
  • Spectrum2_000485
  • Spectrum3_000996
  • Spectrum4_001124
  • Spectrum5_001462
  • Candesartan cilexetil CRS
  • CHEMBL1014
  • MFCD00871371
  • Candesartan Celexetil Ester
  • DTXCID50239
  • UNII-R85M2X0D68
  • GHOSNRCGJFBJIB-UHFFFAOYSA-N
  • C33H34N6O6
  • R85M2X0D68
  • SCHEMBL40831
  • BSPBio_002691
  • KBioGR_001607
  • KBioSS_002187
  • MLS004774127
  • PBCMNDESARTAN CILEXETIL
  • Candesartan cilexetil , 97%
  • NSC-758697
  • SCHEMBL612936
  • SPECTRUM1504261
  • SPBio_000349
  • CHEBI:3348
  • GTPL8352
  • orb1305541
  • Candesartan cilexetil (Atacand)
  • Candesartan N-Cilexetil Impurity
  • Candesartan Cilexetil (Standard)
  • ERK5-3L13
  • KBio2_002187
  • KBio2_004755
  • KBio2_007323
  • KBio3_001911
  • KS-00000IVU
  • CID2540
  • EBD4212
  • TCY 116
  • GLXC-07961
  • HMS1922J09
  • HMS2093E20
  • HMS3651I08
  • HMS5080P17
  • Pharmakon1600-01504261
  • Candesartan cilexetil (JP18/USP)
  • CANDESARTAN CILEXETIL [JAN]
  • ALBB-038627
  • BCP22050
  • CID:2540
  • MSK10658
  • Tox21_302202
  • AC-204
  • BDBM50318907
  • CANDESARTAN CILEXETIL [VANDF]
  • CCG-39530
  • EBC-11266
  • HY-17505R
  • NP3201
  • NSC758697
  • s2037
  • STL451065
  • CANDESARTAN CILEXETIL [MART.]
  • AKOS015894954
  • AKOS015920180
  • C33-H34-N6-O6
  • CANDESARTAN CILEXETIL [USP-RS]
  • CANDESARTAN CILEXETIL [WHO-DD]
  • AB07617
  • ACN-037206
  • AM90293
  • AN-7256
  • BCP9000480
  • CCG-222334
  • CS-2893
  • CS-O-00538
  • DB00796
  • DS-1302
  • EBC-656142
  • FC19661
  • KS-1147
  • NSC 758697
  • VA10473
  • Candesartan cilexetil, >=98% (HPLC)
  • NCGC00095123-01
  • NCGC00095123-02
  • NCGC00095123-03
  • NCGC00095123-05
  • NCGC00095123-10
  • NCGC00095123-16
  • NCGC00255218-01
  • AK-75900
  • BC164274
  • BC209195
  • BR-75900
  • Candesartan cilexetil - Bio-X trade mark
  • Candesartan cilexetil CRS (Y0001388)
  • HY-17505
  • LS-32741
  • SC-12740
  • SID:53790860
  • SMR003500784
  • SY051248
  • CANDESARTAN CILEXETIL [ORANGE BOOK]
  • SBI-0206767.P001
  • AB0012012
  • AB2000442
  • CANDESARTAN CILEXETIL [EP MONOGRAPH]
  • TL8000995
  • 4CH-009595
  • C-265
  • C2635
  • CANDESARTAN CILEXETIL [USP MONOGRAPH]
  • CAS-145040-37-5
  • NS00006138
  • ST24030238
  • SW220041-1
  • Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
  • J1.640.921I
  • A-2005
  • C07709
  • D00626
  • EN300-118698
  • J10436
  • AB01274805-01
  • AB01274805_02
  • AB01274805_03
  • Candesartan cilexetil for peak identification CRS
  • Candesartan cilexetil for system suitability CRS
  • 040C375
  • A848411
  • C077793
  • H212/91
  • L006257
  • SR-05000001976
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
  • Atacand;Amias;Blopress;Ratacand;TCV 116;TCY 116
  • I06-0090
  • SR-05000001976-1
  • BRD-A65671304-001-02-6
  • BRD-A65671304-001-03-4
  • BRD-A65671304-001-07-5
  • BRD-A65671304-001-08-3
  • Q27075664
  • 1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-
  • Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
  • Candesartan cilexetil, 98%, an ATR antagonist - 1G 1g
  • Z1515383338
  • 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
  • 1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
  • 1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate
  • 1261393-19-4
  • Candesartan Cilexetil for System Suitability CRS (Y0001389)
  • CANDESARTAN 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER [MI]
  • (+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
  • 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate
  • 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-
  • 2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER
  • 2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
  • Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard
  • Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard
  • Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard
  • Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard
  • Candesartan Cilexetil, Pharmaceutical Secondary Standard; Certified Reference Material
  • (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate
  • (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate
  • (+/-)-1-HYDROXYETHYL 2-ETHOXY-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)-7-BENZIMIDAZOLECARBOXYLATE, CYCLOHEXYL CARBONATE (ESTER)
  • (1RS)-1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethox
  • 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
  • 1-(1,2,2,3,3,4,4,5,5,6,6-undecadeuteriocyclohexyl)oxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
  • 1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate
  • 1-[[2 -(1H-Tetrazole-5-yl)-1,1 -biphenyl-4-yl]methyl]-2-ethoxy-1H-benzoimidazole-7-carboxylic acid 1-[(cyclohexyloxycarbonyl)oxy]ethyl ester
  • 1-[2 -(1H-Tetrazole-5-yl)-4-biphenylylmethyl]-2-ethoxy-1H-benzoimidazole-7-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
  • 1-[2 -(1H-Tetrazole-5-yl)-4-biphenylylmethyl]-2-ethoxy-1H-benzoimidazole-7-carboxylic acid 1-[(cyclohexyloxy)carbonyloxy]ethyl ester
  • 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzimidazole-7-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate
  • 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate
  • 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl] methyl]benzimidazole-4-carboxylate
  • 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate.
  • 139481-59-7
  • 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, ( -)-
  • 1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID, 2-ETHOXY-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER, (+/-)-
  • 1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
  • 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
  • 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]et hyl ester
  • 2-Ethoxy-1-[2 -(1H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-benzimidazole-7-carboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
  • 2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
  • 2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
  • 2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
  • Candesartan Cilexetil; 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate; 2-Ethoxy-1-[(2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester; Atacand; Blopress; Candesartan cilexetil; TCV 116; TCY 116; (+/-)-2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester; (+/-)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)